Q/C Technologies, Inc. (QCLS) — 10-Q Filings

10-Q Filings (6)

• QCLS Cash Surges on New Capital, Net Loss Narrows to $5.7M — Nov 19, 2025 Risk: high
  Q/C Technologies, Inc. (QCLS) reported a net loss of $5,732,326 for the nine months ended September 30, 2025, a significant improvement from the $21,295,080 net
• TNF Pharmaceuticals Files Q2 2025 10-Q — Aug 19, 2025 Risk: medium
  TNF Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2025. The company, formerly known as MyMD Pharmaceuticals, Inc., is involved in in vitro
• TNF Pharmaceuticals Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  TNF Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as MyMD Pharmaceuticals, Inc., is involved in the in
• TNF Pharmaceuticals Files Q3 2024 10-Q — Nov 14, 2024 Risk: medium
  TNF Pharmaceuticals, Inc. filed its 10-Q for the period ending September 30, 2024. The company, formerly known as MyMD Pharmaceuticals, Inc., is involved in the
• TNF Pharmaceuticals Files Q2 2024 10-Q — Aug 19, 2024 Risk: medium
  TNF Pharmaceuticals, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as MyMD Pharmaceuticals, Inc., is involved in the diag
• MyMD Pharmaceuticals, Inc. Files 10-Q for Period Ending March 31, 2024 — May 15, 2024 Risk: low
  MyMD Pharmaceuticals, Inc. (QCLS) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. MyMD Pharmaceuticals, Inc. filed a 10-Q report for the period en

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX